VI
ABBV icon

Vestcor Inc’s AbbVie ABBV Stock Holding History

Vestcor Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Sell
73,641
-15,029
-17% -$3.33M 0.44% 53
2025
Q4 		$20.3M Sell
88,670
-2,216
-2% -$505K 0.58% 38
2025
Q3 		$21M Sell
90,886
-1,776
-2% -$362K 0.63% 30
2025
Q2 		$17.2M Buy
92,662
+4,812
+5% +$894K 0.52% 42
2025
Q1 		$18.4M Buy
87,850
+9,539
+12% +$1.85M 0.62% 34
2024
Q4 		$13.9M Sell
78,311
-2,733
-3% -$502K 0.46% 51
2024
Q3 		$16M Hold
81,044
– – 0.5% 43
2024
Q2 		$13.9M Buy
81,044
+1,179
+1% +$195K 0.47% 47
2024
Q1 		$14.5M Sell
79,865
-4,568
-5% -$787K 0.5% 42
2023
Q4 		$13.1M Buy
84,433
+6,624
+9% +$966K 0.44% 48
2023
Q3 		$11.6M Buy
77,809
+19,339
+33% +$2.84M 0.42% 50
2023
Q2 		$7.88M Buy
58,470
+10,326
+21% +$1.51M 0.29% 82
2023
Q1 		$7.67M Buy
48,144
+3,221
+7% +$492K 0.28% 79
2022
Q4 		$7.26M Buy
44,923
+312
+0.7% +$47.8K 0.27% 87
2022
Q3 		$5.99M Buy
44,611
+469
+1% +$67.3K 0.23% 102
2022
Q2 		$6.76M Buy
44,142
+16,177
+58% +$2.47M 0.25% 92
2022
Q1 		$4.53M Buy
27,965
+337
+1% +$49K 0.16% 151
2021
Q4 		$3.74M Sell
27,628
-4,876
-15% -$576K 0.13% 175
2021
Q3 		$3.51M Sell
32,504
-3,596
-10% -$411K 0.13% 200
2021
Q2 		$4.07M Sell
36,100
-59,499
-62% -$6.7M 0.14% 180
2021
Q1 		$10.3M Buy
95,599
+9,467
+11% +$1.01M 0.39% 72
2020
Q4 		$9.23M Buy
86,132
+16,342
+23% +$1.57M 0.38% 75
2020
Q3 		$6.11M Buy
69,790
+25,596
+58% +$2.41M 0.28% 105
2020
Q2 		$4.34M Buy
44,194
+9,085
+26% +$800K 0.22% 131
2020
Q1 		$2.67M Buy
35,109
+5,636
+19% +$480K 0.15% 170
2019
Q4 		$2.61M Buy
+29,473
New +$2.45M 0.12% 216

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vestcor Inc's ABBV Position: Q1 2026 in Review

Vestcor Inc reduced its AbbVie (ABBV) stake by 17% in Q1 2026, selling an estimated $3.33M and leaving 73,641 shares worth $16M. The position accounts for 0.44% of the portfolio, ranked #53.

Vestcor Inc first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $21M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vestcor Inc held 73,641 shares of AbbVie worth $16M as of Q1 2026.
  • Vestcor Inc sold 15,029 AbbVie shares in Q1 2026, an estimated $3.33M.
  • AbbVie made up 0.44% of Vestcor Inc's portfolio in Q1 2026, its #53 holding.
  • Vestcor Inc first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Vestcor Inc's AbbVie position peaked at $21M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.